Adolescents have the highest rate of sexually transmitted disease (STD) of any sexually active age group. This article reviews the biological, psychological, and social factors that place adolescents at increased risk for STDs. The major STDs are reviewed, including epidemiology, clinical presentation, methods of diagnosis, and treatment modalities. In addition, major sequelae of STDs &mdash; including pelvic inflammatory disease, perihepatitis, Reiter's syndrome, and disseminated gonorrhea infection &mdash; are discussed. This article continues a four~art series by the same authors. Previous articles covered sexual activity and contraception. The series will conclude next month with an article on the practitioner's role.
Introduction sexually transmitted diseases
(STDs) are a major problem in the adolescent population.' Over one half of the adolescents in the United States are sexually active, and the rates of sexual activity have increased among younger adolescent age groups Sexually active adolescents have the highest rate of STDs of any sexually active age group. [5] [6] [7] [8] Annually, 2.5 million adolescents will have an STD; this corresponds to one out of six sexually active teenagers.9 When exploring possible explanations for this high rate of infection, one should consider a variety of biological and psychosocial factors.
Biological Issues
In general, adolescents have had less lifetime exposure to STDs than adults and therefore have not developed either systemic or local antibodies to these infections. Presumably, the presence of these antibodies would provide some protection. &dquo;,'0 In addition, the adolescent female cervix is biologically immature. The cervix has an ectropion in which columnar cells are present on the exocervix and the transformation zone between columnar and squamous cells is exposed to the vaginal en-vironment. STD pathogens can colonize these columnar cells, causing pathology in the area of the transformation zone and leading to increased morbidity from STDs.7,1o,l1 i Psychosocial Issues Adolescents' unique psychology places them at increased risk for STDs. Effective use of barrier contraceptives, including condoms, is not a hallmark of adolescence. Some increase in the use of condoms has been reported as a result of concerns about STDs and human immunodeficiency virus (HIV) infection, but consistent use of condoms among sexuallã ctive adolescents has not been achieved.&dquo;-&dquo; Education aimed at changing behavior is particularly difficult with adolescents because of their perception that they are invulnerable to harm. Partner acceptance, negotiating relationships, and aesthetics are important in determining the use of condoms. Identification with peers and fitting in with the group's values and behavior are also extremely important aspects of adolescent development.l5~ '6 Social Issues Confidentiality and access to care become important barriers in the prevention and treatment of STDs. Although anyone in the United States is permitted to give consent for the confidential diagnosis and treatment of STDs, adolescents commonly encounter major obstacles.&dquo; Adolescents frequently have difficulty finding a practitioner whom they can trust to provide confidential treatment. Access is also limited by factors of cost and transportation. Medical insurance information may not be readily available to adolescents, and many teenagers cannot afford to pay the fee for service. Even if an adolescent finds a practitioner and can obtain access to health insurance, it is difficult to code the visit or laboratory charges for insurance purposes in a manner that will assure confidentiality. Although free STD clinics exist, teenagers may be reluctant to be seen patronizing them. 16, 17 Clinical Issues Other techniques permit more rapid diagnosis of GC. The presence of gram-negative intracellular diplococci on a urethral Gram stain in a male is diagnostic of GC. The same finding from a cervical specimen in a female, however, only suggests infection, since nongonococcal Neisseria species exist in the normal vaginal flora. Rapid tests to detect GC antigen are available.7
The treatment of choice for GC is 250 mg of ceftriaxone in a single intramuscular injection.
Other oral and intramuscular regimens are available, including oral cefixime, ciprofloxacin, and ceftin/probenecid. These are listed in Chlamydia culture is considered the gold standard for diagnosis. This method, however, is expensive, time-consuming, and not widely available. Alternatives include rapid nonculture methods, such as direct fluorescent antibody (DFA) and enzyme immunoassay (EIA) . Unfortunately, both methods can yield false-positive and false-negative results. Although DFA allows the technician to evaluate the adequacy of the specimen, the results depend upon the skill of the reader. The objective EIA method uses spectrephotometric readings but is less sensitive than the other techniques and does not permit evaluation of specimen quality.''~28 DFA, EIA, and culture are invasive procedures, particularly for males. Some authors have advocated the use of a urine dipstick to detect leukocyte esterase in the first part of a voided specimen as a screening method for STDs in the male. The dipstick method represents a noninvasive test that can help guide decisions about pursuing invasive evaluations, especially in asymptomatic males. 33,37,38 The urine dipstick method has also been favorably evaluated in random urine specimens.24
Since chlamydial testing is not widely available, and GC and chlamydia commonly occur together, the CDC recommends that all individuals treated for GC be treated for chlamydia as well. The treatment for chlamydia is outlined in Table 2 . Doxycycline is frequently preferred, because it needs to be given only twice daily and its absorption is not affected by food intake. Furthermore, doxycycline is associated with less severe gastrointestinal side effects than is erythromycin. Neither doxycycline nor tetracycline can be used in
for the treatment of chlamydial infection. This is a welcome alternative, especially in a noncompliant population.39-41
Disseminated Disease
Pelvic inflammatory disease (PID) is a common complication of both GC and chlamydia. 7, 9, 42 As with STDs in general, adolescent females have the highest age-spe-cific rates for PID. Twenty percent t of all PID occurs among adolescents.' The risk that a sexually active 15-year-old will acquire PID is one in eight. 43 Up to one fifth of women with gonorrhea will develop PID; in the United States, 38% to 52% of PID infections are secondary to chlamydial infections.' There have been re-ports that 10% to 40% ofwomen with untreated GC or chlamydia will develop PID.1l, 18, 42 PID is a polymicrobial disease characterized by infection in the uterus, fallopian tubes, and contiguous pelvic structures. GC and chlamydia initiate changes in the genital tract that permit overgrowth of other bacteria, such as anaerobes and endogenous vaginal flora, with subsequent infection in the upper genital tract. Some authors have suggested that bacterial vaginosis may also be a risk factor for PID, since the vaginal flora changes associated with this infection may be similar to those that occur in PID. 7, 11, 42 The diagnosis of PID is made clinically ( Sequelae of PID include infertility, ectopic pregnancy, chronic abdominal pain, tubo-ovarian abscess, and recurrent PID. 7,8,42 The risk of infertility is 11 % after the first episode, 23% after the second, and 54% or more after the third. 7 7 Although PID can be treated on an outpatient basis, many clinicians would recommend inpatient treatment for adolescents because of noncompliance, potential serious sequelae, and the possibility of a mistaken diagnosis (Table 4) . 11, 43 Perihepatitis (Fitz-Hugh-Curtis syndrome) is associated with both GC and chlamydia. In one study, The organism may be identified by examining saline preparations of cervical or vaginal secretions. The specimen must be examined immediately to avoid cooling or drying and decreased motility of the organism. Saline preparations will fail to detect the organism up to 25% of the time.7 7 T. vaginalis may also be detected on Pap smears. Although culture and fluorescent antibody tests exist, they are not widely available.
As outlined in Table 5 This infection may be diagnosed by finding buds or branching hyphae on microscopic evaluation of vaginal secretions in saline or 10% KOH. The fungi can also be grown in culture. A positive culture must be evaluated within the context of the clinical picture, however, since candida can be part of the normal vaginal flora. Conditions that predispose to this infection include diabetes, pregnancy, and antibiotic use. Various therapeutic regimens are available; these range from 1 to 7 days (Table  8 ). Some in the genital region: types 6, 11, 16,18, 31, 33, 35, 39, 45, 51, and 52. In one study, up to 38% of sexually active adolescent females were found to be positive for HPV DNA by the Southern blot method. 56 Forty-six percent of college students presenting for routine gynecologic care were positive by polymerase chain reaction (PCR) analysis, while 92% with a Pap smear abnormality were found to have HPV. 57
The natural history of HPV infection needs further investigation. One study of adolescent females followed the same cohort over time (6 to 36 months) ?8 The authors found that, although 57% of the subjects were positive at least once during the study period, only 8% of the subjects were positive at both times. In addition, the same HPV type was detected at both vis, its for only one in 51 subjects. (Table 10) include laser vaporization, cryotherapy with liquid nitrogen or a cryoprobe, podophyllin, trichloroacetic acid, electrodesiccation, electrocautery, intralesional interferon, and 5-fluorouracil.~ ~ Podophyllin can be used on the external genitalia. It can, however, cause irritation and is contraindicated in pregnancy because of systemic absorption and teratogenicity. Twenty percent to 85% trichloroacetic acid is currently preferred for topical therapy. The goal of any therapeutic modality is to treat cervical abnormalities and relieve symptoms. Most clinicians believe that it is impossible to eradicate the virus completely. Although imperfect, use of barrier methods of contraception is the best preventive measure in the sexually active population. 18,64
Human lmmunodrificiency Virus
A detailed discussion of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) is beyond the scope of this article. Nevertheless, a few points should be made in view of the importance of this infection. Given the long latency period associated with HIV infection, many individuals who present with AIDS in their 20s were actually infected during adolescence. [67] [68] [69] [70] Seroprevalence data related to adolescents have emerged from various studies that used different survey modalities and target populations. These studies have included military recruits (0.03%),71 Job Corps entrants (0.39%),72 runaway youth (7%),73 college students (0.2%),74 and adolescents attending STD clinics (2.2%),75 a general adolescent health clinic (0.37%) ,68 or a hospital emergency room ( 1.2 % ) .68 These data represent overall rates. When analyzed by sex, age, and race or ethnic background, these data suggest that adolescent females may be at greater risk than adult women; that African-American and Hispanic teens are at greater risk than white teens; and that HIV rates increase with age. [67] [68] [69] [70] National data concerning adolescents with AIDS show that 73% were infected by intravenous drug use or sexual activity, 22% were exposed to infected blood or blood products, and the cause was undetermined in 5% of cases .76 It is not possible to generalize about the methods of transmission of HIV, since regional differences exist throughout the country and large regional clusters of HIV infection skew the data. For example, outside large endemic areas, the leading cause of HIV infection for young adolescent males is transfusion of infected blood or blood products. 67 Heterosexual contact is the most common means of exposure for adolescent females. 71
Certain types of adolescent behavior contribute to the risk of HIV infection in this age group. This includes sexual activity without the use of condoms; multiple sexual partners; high rates of STDs, including those associated with genital ulcers; substance abuse; and feelings of invulnerability to harm. Preventing HIV infection in adolescents requires education and counseling, ideally beginning before the onset of sexual activity. Addressing adolescent developmental issues that affect decisions to engage in risk-taking behavior is another crucial element of this effort. [67] [68] [69] [70] Conclusion STDs are a major source of morbidity in the sexually active adolescent population. Discussing abstinence as the only foolproof method of prevention is worthwhile, but mentioning condoms should be included for those who do not choose abstinence. Practitioners who treat adolescents must be familiar with the diagnosis and treatment of STDs as well as the need to identify asymptomatic infection.
